
BROKER MOVES: NKE upgraded at Truist Secs, believing the Co. is moving in the right direction; PYPL downgraded at Bernstein
UPGRADES
- Acadia Realty (AKR) Upgraded to Buy at Compass Point; PT USD 27
- AIG (AIG) Upgraded to Overweight at JPMorgan; PT USD 89
- Bank of Marin (BMRC) Upgraded to Buy at DA Davidson; PT USD 24
- Brinker (EAT) Upgraded to Neutral at BofA; PT USD 90
- Carrier Global (CARR) Upgraded to Neutral at JPMorgan; PT USD 83
- CVS (CVS) Upgraded to Overweight at Barclays; PT USD 82
- Exxon (XOM) Upgraded to Sector Outperform at Scotiabank; PT USD 145
- Fortive (FTV) Upgraded to Overweight at JPMorgan; PT USD 92
- L3Harris (LHX) Upgraded to Outperform at Wolfe; PT USD 300
- LendingClub (LC) Upgraded to Outperform at KBW; PT USD 15
- Medtronic (MDT) Upgraded to Outperform at RBC; PT USD 105
- Nike (NKE) Upgraded to Buy at Truist Secs; PT USD 97
- TransUnion (TRU) Upgraded to Outperform at Wolfe; PT USD 130
DOWNGRADES
- American Tower (AMT) Downgraded to Equal-Weight at Wells Fargo; PT USD 230
- Arcadium Lithium (ALTM) Downgraded to Hold at HSBC; PT USD 5.85
- Arcadium Lithium (ALTM) Downgraded to Market Perform at Raymond James
- Centrus Energy (LEU) Downgraded to Neutral at Roth Capital Partners; PT USD 62
- Cirrus Logic (CRUS) Downgraded to Equal-Weight at Barclays
- First Advantage (FA) Downgraded to Peerperform at Wolfe
- Hexcel (HXL) Downgraded to Hold at Vertical Research; PT USD 65
- Honeywell (HON) Downgraded to Neutral at JPMorgan; PT USD 235
- Hubbell (HUBB) Downgraded to Neutral at JPMorgan; PT USD 454
- Huntington Ingalls (HII) Downgraded to Hold at Vertical Research; PT USD 275
- Huntington Ingalls (HII) Downgraded to Peerperform at Wolfe
- Lululemon (LULU) Downgraded to Hold at CFRA
- Organon (OGN) Downgraded to Sell at CFRA
- PayPal (PYPL) Downgraded to Market Perform at Bernstein; PT USD 80
- PepsiCo (PEP) Downgraded to Hold at TD Cowen; PT USD 183
- Saratoga Investment (SAR) Downgraded to Neutral at Ladenburg Thalmann
- Skyworks (SWKS) Downgraded to Underweight at Barclays
INITIATIONS
- Acadia Pharma (ACAD) Reinstated Market Perform at Raymond James
- Agios (AGIO) Re-Initiated Outperform at Raymond James; PT USD 51
- Align Technology (ALGN) Initiated at New Hold at Needham
- Amer Sports (AS) Initiated at New Buy at William O'Neil
- Banc of California (BANC) Initiated at New Neutral at Citi
- Biogen (BIIB) Reinstated Market Perform at Raymond James
- BioMarin (BMRN) Reinstated Outperform at Raymond James; PT USD 79
- Birkenstock (BIRK) Initiated at New Buy at BTIG; PT USD 60
- Builders FirstSource (BLDR) Initiated at New Buy at Goldman; PT USD 225
- Capital Clean Energy Car (CCEC) Initiated at New Buy at Fearnley; PT USD 22
- Denali Therapeutics (DNLI) Reinstated Market Perform at Raymond James
- Harmony Biosciences (HRMY) Reinstated Outperform at Raymond James
- Immunovant (IMVT) Reinstated Outperform at Raymond James; PT USD 36
- MARA Holdings Inc (MARA) Initiated at New Overweight at Cantor; PT USD 21
- Milestone Scientific (MLSS) Initiated at New Speculative Buy at Benchmark
- Monday.com (MNDY) Initiated at New Overweight at Capital One; PT USD 325
- Neurocrine Bio (NBIX) Reinstated Outperform at Raymond James; PT USD 155
- OnKure Therapeutics Inc (OKUR) Initiated at New Outperform at Oppenheimer
- P&G (PG) Initiated at New Neutral at DA Davidson; PT USD 159
- PTC Therapeutics (PTCT) Reinstated Market Perform at Raymond James
- Regenxbio (RGNX) Reinstated Outperform at Raymond James; PT USD 18
- Sage Therapeutics (SAGE) Reinstated Market Perform at Raymond James
- Sarepta (SRPT) Reinstated Outperform at Raymond James; PT USD 150
- SiteOne Landscape (SITE) Initiated at New Neutral at Goldman; PT USD 158
- SouthState Corp (SSB) Initiated at New Neutral at Citi
- Sunnova Energy (NOVA) Initiated at New Buy at Jefferies; PT USD 15
- Synovus (SNV) Initiated at New Buy at Citi
- TXNM Energy Inc (TXNM) Initiated at New Sector Perform at Scotiabank; PT USD 46
- UMB Financial (UMBF) Initiated at New Buy at Citi
- uniQure (QURE) Reinstated Outperform at Raymond James; PT USD 20
- Veracyte (VCYT) Initiated at New Buy at Guggenheim; PT USD 40
- Vertex Pharmaceuticals (VRTX) US Reinstated Market Perform at Raymond James
- Xenon Pharmaceuticals (XENE) Reinstated Outperform at Raymond James
10 Oct 2024 - 12:21- - Source: Newswires
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts